SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. The company is headquartered in Santa Clara, California and currently employs 349 full-time employees. The company went IPO on 2018-10-17. The firm specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The firm's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The firm's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Follow-Up Questions
What is SI-BONE Inc (SIBN)'s P/E Ratio?
The P/E ratio of SI-BONE Inc is N/A
Who is the CEO of SI-BONE Inc?
Ms. Laura Francis is the Chief Executive Officer of SI-BONE Inc, joining the firm since 2015.
What is the price performance of SIBN stock?
The current price of SIBN is 15.19, it has increased 0.07% in the last trading day.
What are the primary business themes or industries for SI-BONE Inc?
SI-BONE Inc belongs to Health Care industry and the sector is Health Care
What is SI-BONE Inc market cap?
SI-BONE Inc's current market cap is $655.3
Is SI-BONE Inc a buy, sell, or hold?
According to wall street analysts, 11 analysts have made analyst ratings for SI-BONE Inc, including 4 strong buy, 10 buy, 1 hold, 0 sell, and 4 strong sell
